Floatz logo

tqb2618

Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes cohort.

Asset / SponsorPhaseRating
Decitabine
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1CC

Same molecule, other indications

tqb2618 is also rated in:

lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
cancerDormant
CC
Indicative ·
45 / 100
View asset →
hepatocellular carcinomaDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →